Dual role for nitric oxide in dynorphin spinal neurotoxicity

Journal of Neurotrauma

Volumn 16, Issue 1, 1999, Pages 85-98

  Hu, Wen Hui ^a,b   Li, Fang ^a   Qiang, Wen An ^b   Liu, Na ^b   Wang, Guo Qiang ^a   Xiao, Jian ^a   Liu, Jing Sheng ^b   Liao, Wei Hong ^a   Jen, Min Feng ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Dynorphin; Nitric oxide; Rat; Spinal cord injury

Indexed keywords

7 NITROINDAZOLE; AMINOGUANIDINE; CITRULLINE; DYNORPHIN; N(G) METHYLARGININE; NITRIC OXIDE; SPERMINE;

ANIMAL EXPERIMENT; ARTICLE; ENZYME ACTIVITY; HINDLIMB; IMMUNOREACTIVITY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARALYSIS; PARAPLEGIA; RAT; SPINAL CORD INJURY; VASCULAR ENDOTHELIUM;

EID: 0032941893     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1999.16.85     Document Type: Article

References (72)

1. BAKSHI, R., and FADEN, A.I. (1990). Competitive and noncompetitive NMDA antagonists limit dynorphin A-induced rat hindlimb paralysis. Brain Res. 507, 1-5.
2. BEHRMANN, D.L., BRESNAHAN, J.C., and BEATTIE, M.S. (1993). A comparison of YM-14673, U-50488H and nalmefene after spinal cord injury in rat. Exp. Neurol. 119, 259-267.
3. BLOT, S., AMAL, J.F., XU, Y., GRAY, F., and MICHEL, J.-B. (1994). Spinal cord infarcts during long-term inhibition of nitric oxide synthase in rats. Stroke 25, 10-16.
4. BREDT, D.S., and SNYDER, S.H. (1990). Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U.S.A. 87, 682-685.
5. ω-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonist. Circ. Res. 72, 387-395.
6. CHEN, B., TIAN, X.F., and JEN, M.F. (1995). Dynorphin-induced spinal cord injury in rats. Chin. J. Pharmacol. Toxicol. 9, 36-39.
7. DALKARA, T., MORIKAWA, E., PANHANIAN, N., and MOSKOWITZ, M.A. (1994). Blood flow-dependent function recovery in a rat model of focal ischemia. Am. J. Physiol. 267, H678-H683.
8. DALKARA, T., and MOSKOWITZ, M.A. (1994). The complex role of nitric oxide in the pathophysiology of focal cerebral ischemia. Brain Pathol. 4, 49-57.
9. DAWSON, T.M., DAWSON, V.L., and SNYDER, S.H. (1994). Molecular mechanism of nitric oxide actions in the brain. Ann. N.Y. Acad. Sci. 738, 76-85.
10. DAWSON, V.L., DAWSON, T.M., BARTLEY, D.A., UHL, G.R., and SNYDER, S.N. (1993). Mechanism of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13, 2651-2661.
11. 3H]CGP-39653 binding to rat brain membranes. Eur. J. Pharmacol. 271, 241-244.
12. FADEN, A.I. (1990). Opioid and nonopioid mechanisms may contribute to dynorphin's pathophysiological actions in spinal cord injury. Ann. Neurol. 27, 67-74.
13. FADEN, A.I., TAKEMORI, A.E., and PRITOGHESE, P.S. (1987). Kappa-selective opiate antagonist nor-binaltorphimine improves outcome after traumatic spinal cord injury in rats. C.N.S. Trauma 4, 227-237.
14. FARACI, F.M., and BRIAN, JR, J.E. (1994). Nitric oxide and the cerebral circulation. Stroke 25, 692-703.
15. FARACI, F.M., and BRIAN, JR., J.E. (1995). 7-Nitroindazole inhibits brain nitric oxide synthase and cerebral vasodilatation in response to W-methyl-D-aspartate. Stroke 26, 2172-2176.
16. FIYIBAYASHI, K., and IIZUKA, Y. (1995). Profiles of the antinociceptive effects of R-84760, a selective κ-opioid receptor agonist, in formalin test in mice. Jpn. J. Pharmacol. 68, 57-63.
17. GARTHWAITE, J., and BOULTON, C.L. (1995). Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57, 683-706.
18. GLOBUS, M.Y.T., PRADO, R., SANCHEZ-RAMOS, J., et al. (1995). A dual role for nitric oxide in NMDA-mediated toxicity in vivo. J. Cereb. Blood Flow Metab. 15, 904-953.
19. GROSS, S.S., and WOLIN, M.S. (1995). Nitric oxide: pathophysiological mechanism. Annu. Rev. Physiol. 57, 737-769.
20. HERDEGEN, T., BRECHT, S., MAYER, B., et al. (1993). Long-lasting expression of JUN and KROX transcription factors and nitric oxide synthase in intrinsic neurons of the rat brain following axotomy. J. Neurosci. 13, 4130-4145.
21. HEWETT, S.J., CORBETT, I.A., McDANIEL, M.L., and CHOI, D.W. (1993). Inhibition of nitric oxide formation does not protect murine cortical cell cultures from N-methyl-D-aspartate neurotoxicity. Brain Res. 625, 337-341.
22. HEWETT, S.J., CSERNANSKY, C.A., and CHOI, D.W. (1994). Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron 13, 487-494.
23. HOOPER, D.C., OHNISHI, S.T., KEAN, R., NUMAGAMI, Y. DIETZSCHOLD, B., and KOPROWSKI, H. (1995). Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 92, 5312-5316.
24. 2+ in cultured rat forebrain neurons. Brain Res. 592, 310-316.
25. HU, W.H., LEE, F.C.H., WAN, X.S.T., CHEN, Y.T., and JEN, M.F. (1996). Dynorhpin neurotoxicity induced nitric oxide synthase expression in ventral horn cells of rat spinal cord. Neurosci. Lett. 203, 13-16.
26. 2+ concentration in cultured rat spinal neurons. Eur. J. Pharmacol. 342, 325-332.
27. HUANG, Z., HUANG, P.L., PANAHIAN, N., DALKARA, T., FISHMAN, M.C., and MOSKOWITZ, M.A. (1994). Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265, 1883-1885.
28. IADECOLA, C. (1997). Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20, 132-139.
29. IADECOLA, C., PELLIGRINO, D.A., MOSKOWITZ, M.A., and LASSEN, N.A. (1994). State of the art review. Nitric oxide synthase inhibition and cerebrovascular regulation. J. Cereb. Blood Flow Metab. 14, 175-192.
30. IADECOLA, C., XU, X., ZHANG, F., EL-FAKAHANY, E.E., and ROSS, M.E. (1995a). Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 15, 52-59.
31. IADECOLA, C., ZHANG, F., and XU, X. (1995b). Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol. 268, R286-R292.
32. IZUMI, Y., BENZ, A.M., CLIFFORD, D.B., and ZORUMSKI, C.F. (1992). Nitric oxide inhibitors attenuate N-methyl-D-aspartate excitotoxicity in rat hippocampal slices. Neurosci. Lett. 135, 227-230.
33. KUPPUSAMY, P., OHNISHI, S.T., NUMAGAMI, Y., OHNISHI, T., and ZWEIER, J.L. (1995). Three-dimensional imaging of nitric oxide production in the rat brain subjected to ischemia-hypoxia. J. Cereb. Blood Flow Metab. 15, 899-903.
34. LAFON-CAZAL, M., CULCASI, M., GAVEN, F., PIETRI, S., and BOCKAERT, J. (1993). Nitric oxide, superoxide and peroxynitrite, Putative mediators of NMDA-induced cell death in cerebellar granule cells. Neuropharmacology 32, 1259-1266.
35. LI, F.C., ZUO, P.P., HU, W.H., LIU, N., and JEN, M.F. (1997). Glutamate involvement in rats with spinal cord injury induced by dynorphin A(1-17). Chin. J. Rehabil. Theory Pract. 3, 6-9.
36. LIPTON, S.A., CHOI, Y.B., PAN, Z.H., et al. (1993). A redox-based mechanism for neuroprotective and neurodestructive effects of NO. Nature 364, 626-632.
37. LIU, R.H., and HOTCHKISS, J.H. (1995). Potential genotoxicity of chronically elevated nitric oxide. A review. Mutat. Res. 339, 73-89.
38. LONG, J.B., RIGAMONTI, D.D., OLESHANSKY, M.A., WINGFIELD, C.P., and MARTINEZ-ARIZALA, A. (1994). Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury. J. Pharmacol. Exp. Ther. 269, 358-366.
39. LONG, J.B., and SKOLNICK, P. (1994). 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury. Eur. J. Pharmacol. 261, 295-301.
40. MACKENZIE, G.M., JENNER, P., and MARSDON, C.D. (1995). The effect of nitric oxide synthase inhibition on quinolinic acid toxicity in the rat striatum. Neuroscience 67, 357-371.
41. MANZONI, O., and BOEKAERT, J. (1993). Nitric oxide synthase activity endogenously modulates NMDA receptors. J. Neurochem. 61, 368-370.
42. MASSARDIER, D., and HUNT, P.F. (1989). A direct non-opiate interaction of dynorphin-1(1-13) with the N-methyl-D-aspartate (NMDA) receptor. Eur. J. Pharmacol. 170, 125-126.
43. 2+/calmodulin-dependent nitric oxide synthase from porcine cerebellum. F.E.B.S. Lett. 227, 215-219.
44. MESENGE, C., VERRECCHIA, C., ALLIX, M., BOULU, R.R., and PLOTKINE, M. (1996). Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors. J. Neurotrauma 13, 209-214.
45. MILLAN, M.J. (1990). κ-Opioid receptors and analgesia. Trends Pharmacol. Sci. 11, 70-76.
46. MONCADA, C., LEKTEFFRE, D., ARVIN, B., and MELDRUM, B. (1992). Effect of NO synthase inhibition on NMDA and ischemia-induced hippocampal lesions. Neuroreport 3, 530-532.
47. MORIKAWA, E., MOSKOWITZ, M., HUANG, Z., YOSHIDA, T., IRIKURA, K., and DALKARA, T. (1994). L-Arginine infusion promotes nitric oxide-dependent vasodilation, increase rCBF and reduces infarct volume in the rat. Stroke 25, 429-435.
48. MORRIS, JR., S.M., and BILLIAR, T.R. (1994). New insight into the regulation of inducible nitric oxide synthesis. Am. J. Physiol. 266, E829-839.
49. MOSKOWITZ, M.A., SAITO, K., BREZINA, L., et al. (1987). Nerve fibers surrounding intracranial and extracranial vessels from human and other species contain dynorphin-like irnmunoreactivity. Neuroscience 23, 731.
50. PAUWELS, P.J., and LEYSEN, J.E. (1992). Blockade of nitric oxide formation does not prevent glutamate-induced neurotoxicity in neuronal cultures from rat hippocampus. Neurosci. Lett. 143, 27-30.
51. REIFE, D.W. (1993). Delayed production of nitric oxide contributes to NMDA-mediated neuronal damage. Neuroreport 4, 566-568.
52. RESTA, T.C., and WALKER, B.R. (1996). Chronic hypoxia selectively augments endothelium-dependent pulmonary arterial vasodilation. Am. J. Physiol. 270, H888-H961.
53. RIBEIRO, M.O., ANTUNES, E., DE NUCCI, G., LOVISOLO, S.M., and ZATS, R. (1992). Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 20, 298-303.
54. ROSSITER, J.P., RIOPELLE, R.J., and BISBY, M.A. (1996). Axotomy-induced apoptotic cell death of neonatal rat facial motoneurons, time course analysis and relation to NADPH-diaphorase activity. Exp. Neurol. 138, 33-44.
55. SATO, S., TOMINAGA, T., OHNISHI, T., and OHNISHI, S.T. (1994). Electron paramagnetic resonance study on the time course of nitric oxide production during rat brain ischemia and reperfusion. Brain Res. 647, 91-96.
56. SCHMIDT, W., WOLF, G., CALKA, J., and SCHMIDT, H.H.H.W. (1995). Evidence for bidirectional changes in nitric oxide synthase activity in the rat striatum after excitotoxically (quinolinic acid) induced degeneration. Neuroscience 67, 345-356.
57. SCHULZ, J.B., MATTHEWS, R.T., JENKINS, B.G. (1995). Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15, 8419-8429.
58. SHUKLA, V.K., BANSINATH, M., DUMONT, M., and LEMAIRE, S. (1992). Selective involvement of opioid and phencylidine receptors in the analgesia and motor effects of dynorphin-A-(1-13)-Tyr-Leu-Phe-Asn-Gly-Pto. Brain Res. 591, 176-180.
59. SHUKLA, V.K., and LEMAIRE, S. (1994). Non-opioid effect of dynorphins: possible role of the NMDA receptor. Trends Pharmacol. Sci. 15, 420-424.
60. TIAN, X.F., CHEN, B., and JEN, M.F. (1994). The study on the mechanisms underlying dynorphin spinal neurotoxicity. Chin. J. Physiol. Sci. 10, 289-297.
61. UMANS, J.G., and LEVI, R. (1995). Nitric oxide in the regulation of blood flow and arterial pressure. Annu. Rev. Physiol. 57, 771-790.
62. VAN DAM, A.M., BAUER, J., MAN-A-HING, W.K.H., MARQUETTE, C., TILDERS, F.J.H., and BERKENBOSCH, F. (1995). Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin. J. Neurosci. Res. 40, 251-260.
63. ω-nitro-L-arginine of L-glutamate-induced neurotoxicity in cultured neonatal rat cortical neurons: prolonged application enhances neuroprotective efficacy. Neuroscience 55, 893-901.
64. WU, W., LIUZZI, F.J., SCHINCO, P.P., et al. (1994). Neuronal nitric oxide synthase is induced in spinal neurons by traumatic injury. Neuroscience 61, 719-726.
65. YAKSH, T.L., and RUDY, T.A. (1976). Chronic catheterization of the spinal sub-arachnoid space. Physiol. Behav. 17, 1031-1036.
66. YOSHIDA, T., LIMMROTH, V., IRIKURA, K., and MOSKOWITZ, M.A. (1994). The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine on pial vessel. J. Cereb. Blood Flow Metab. 14, 924-929.
67. ZHANG, F., CASEY, R., ROSS, M.E., and IADECOLA, C. (1996). Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke 27, 317-323.
68. ZHANG, Z.G., CHOPP, M., BAILEY, T., and MALINSKI, T. (1995b). Nitric oxide changes in the rat brain after transient middle cerebral artery occlusion. J. Neuro. Sci. 128, 22-27.
69. ZHANG, Z.G., CHOPP, M., GAUTAM, S., et al. (1994). Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat. Brain Res. 654, 85-95.
70. ZHANG, F., and IADECOLA, C. (1994). Reduction of focal cerebral ischemic damage by delayed treatment with nitric oxide donors. J. Cereb. Blood Flow Metab. 14, 574-601.
71. ZHANG, J., and SNYDER, S.H. (1995). Nitric oxide in the nervous system. Annu. Rev. Pharmacol. Toxicol. 35, 213-233.
72. ZHANG, F., XU, S., and IADECOLA, C. (1995a). Time dependence of effect of nitric oxide synthase inhibition on cerebral ischemic damage. J. Cereb. Blood Flow Metab. 15, 595-601.